Literature DB >> 22361378

Electrodiagnostic approach to the patient with suspected myopathy.

David Lacomis1.   

Abstract

Electrodiagnostic testing is a useful component of the approach to a patient with suspected myopathy. It follows the history and is guided by the neurologic examination findings. Uncovering various electrodiagnostic patterns (eg, fibrillation potentials with short-duration motor unit potentials, short-duration motor unit potentials without fibrillation potentials, myotonic discharges, and short-duration motor unit potentials with complex repetitive discharges) can lead to more targeted laboratory testing and a refined differential diagnosis. Electromyography may also be used to detect subclinical myopathy, assess disease activity, and help select a suitable muscle for biopsy. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22361378     DOI: 10.1016/j.ncl.2011.12.007

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

1.  Rapid identification of human muscle disease with fibre optic Raman spectroscopy.

Authors:  James J P Alix; Maria Plesia; Gavin R Lloyd; Alexander P Dudgeon; Catherine A Kendall; Channa Hewamadduma; Marios Hadjivassiliou; Christopher J McDermott; Gráinne S Gorman; Robert W Taylor; Pamela J Shaw; John C C Day
Journal:  Analyst       Date:  2022-05-30       Impact factor: 5.227

2.  Proximal Limb Weakness in a Patient with Celiac Disease: Copper Deficiency, Gluten Sensitivity, or Both as the Underlying Cause?

Authors:  J David Avila; David Lacomis
Journal:  Case Rep Neurol Med       Date:  2016-11-22

3.  A cola-induced hypokalemic rhabdomyolysis with electromyographic evaluation: A case report.

Authors:  Davide Ferrazzoli; Annarita Sabetta; Grazia Palamara; Luca Caremani; Marina Capobianco; Pietro Balbi; Giuseppe Frazzitta
Journal:  SAGE Open Med Case Rep       Date:  2017-02-23

4.  Subclinical myopathic changes in COVID-19.

Authors:  Davide Villa; Gianluca Ardolino; Linda Borellini; Filippo Cogiamanian; Maurizio Vergari; Valeria Savojardo; Flora Peyvandi; Sergio Barbieri
Journal:  Neurol Sci       Date:  2021-07-25       Impact factor: 3.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.